摘要:
The present invention provides a method for production or detection of a cardiomyocyte(s) and/or cardiac progenitor cell(s), comprises extracting a cardiomyocyte(s) and/or cardiac progenitor cell(s) from a cell population comprising cardiomyocytes and/or cardiac progenitor cells using as an index VCAM1 positivity.
摘要:
The present invention provides a cardiomyocyte- and/or cardiac progenitor cell-proliferating agent comprising at least one compound selected from the group consisting of: a GSK3β inhibitor, ERK dephosphorylation inhibitor, Raf activator, CaMK2 inhibitor and p38 inhibitor; and a method for proliferating cardiomyocytes and/or cardiac progenitor cells using the agent.
摘要:
A method for proliferating cardiomyocytes and/or cardiac progenitor cells is disclosed. The proliferation method includes contact with at least one compound such as a GSK3β inhibitor, ERK dephosphorylation inhibitor, Raf activator, CaMK2 inhibitor and p38 inhibitor. The cardiomyocyte and the cardiac progenitor cell may be a human cardiomyocyte or human cardiac progenitor cell and may be obtained from differentiation of induced pluripotent stem cells.
摘要:
The present invention provides a method for production or detection of a cardiomyocyte(s) and/or cardiac progenitor cell(s), comprises extracting a cardiomyocyte(s) and/or cardiac progenitor cell(s) from a cell population comprising cardiomyocytes and/or cardiac progenitor cells using as an index VCAM1 positivity.
摘要:
The present invention provides a method for producing a myocardial sheet using a group of cells derived from embryonic stem cells. This method is characterized by mixing Flk/KDR positive cells, cardiomyocytes, endothelial cells, and mural cells, all derived from embryonic stem cells, and culturing the mixed cells. Furthermore, the myocardial sheet can be used as a therapeutic agent for heart diseases since VEGF is released from the sheet.
摘要:
The present invention relates to a liquid crystal compound that can be used as a base for injection formulations. The present invention provides an amphipathic compound having the following general formula (I): wherein X and Y each denotes a hydrogen atom or together denote an oxygen atom, n denotes an integer from 0 to 2, m denotes the integer 1 or 2, and R denotes a hydrophilic group generated by removal of one hydroxyl group from any one selected from the group consisting of glycerol, erythritol, pentaerythritol, diglycerol, triglycerol, xylose, sorbitol, ascorbic acid, glucose, galactose, mannose, dipentaerythritol, maltose, mannitol, and xylitol; as well as a base for injection formulations and depot formulation comprising the same.
摘要:
A refrigerator has a refrigerating cycle sequentially connecting a compressor, a condenser, a drawing mechanism, and evaporator, an accumulator, an inlet temperature sensor and an outlet temperature sensor for detecting the temperatures of the inlet and outlet of the evaporator, and a cooling fan for cooling the compressor. When the difference between the temperature detected by the inlet temperature sensor and the temperature detected by the outlet temperature sensor is a predetermined value or more, the cooling fan is stopped.
摘要:
A plunger pump, includes: a plunger pump unit including a pump chamber and a plunger for pressing a hydraulic fluid in the pump chamber to perform a discharging operation of the hydraulic fluid; a motor; and a cam portion driven by the motor to rotate and press the plunger. The cam portion has at least two discharge regions for pressing the plunger and a suction region formed between the discharge region. The plunger performs the discharging operation two times or more by one rotation of the cam portion.
摘要:
A catalyst obtained by contacting (A) a compound of a transition metal of the group V of the Periodic Table represented by formula (I):R.sub.n M(O).sub.m X.sub.p .cndot.L.sub.a (I)wherein M represents a transition metal of the group V of the Periodic Table; R represents a cyclopentadienyl group, a substituted cyclopentadienyl group, an indenyl group, a substituted indenyl group, a fluorenyl group or a substituted fluorenyl group; O represents an oxygen atom; X represents a hydrogen atom, a halogen atom, a hydrocarbon group having 1 to 20 carbon atoms, an alkoxy group, an aryloxy group or an amido group; L represents a Lewis basic compound; n, m, and p each represent an integer selected to make a combination of (n=1, m=1, p=2), (n=1, m=0, p=3), (n=2, m=0, p=1) or (n=1, m=0, p=2); and a represents 0, 1 or 2, and (B) at least one of (B1) an ionic compound comprising a non-coordinating anion and a cation and (B2) an aluminoxane, provided that the component (B) is an ionic compound comprising a non-coordinating anion and a cation (B1) when the combination of n, m, and p of the component (A) is (n=2, m=0, p=1) or (n=1, m=0, p=2).